CellCentric is a biotechnology company developing an oral small molecule drug targeting cancer drivers MYC and IRF4 for the treatment of multiple myeloma.

PBS Biotech develops and enhances single-use bioreactor systems and bioprocess development services to improve the production of therapeutic cells for regenerative medicines.

TRexBio is a biotechnology company developing novel therapies for inflammatory diseases using their Deep Biology platform to focus on immune homeostasis.

Alentis Therapeutics is a biotech company developing antibody-drug conjugates for treating Claudin-1 positive tumors and organ fibrosis.

Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.